Molecular-level simulation of pandemic influenza glycoproteins
- PMID: 22183559
- PMCID: PMC3352029
- DOI: 10.1007/978-1-61779-465-0_34
Molecular-level simulation of pandemic influenza glycoproteins
Abstract
Computational simulation of pandemic diseases provides important insight into many disease features that may benefit public health. This is especially true for the influenza virus, a continuing global pandemic threat. Molecular or atomic-level investigation of influenza has predominantly focused on the two major virus glycoproteins, neuraminidase (NA) and hemagglutinin (HA). In this chapter, we walk the readers through major considerations for studying pandemic influenza glycoproteins, from choosing the most useful choice of system(s) to avoiding common pitfalls in experimental design and execution. While a brief discussion of several potential simulation and docking techniques is presented, we emphasize molecular dynamics (MD) and Brownian dynamics (BD) simulation techniques and molecular docking, within the context of biologically outstanding questions in influenza research.
Similar articles
-
Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic.J Virol. 2012 Sep;86(17):9221-32. doi: 10.1128/JVI.00697-12. Epub 2012 Jun 20. J Virol. 2012. PMID: 22718832 Free PMC article.
-
Hemagglutinin and neuraminidase matching patterns of two influenza A virus strains related to the 1918 and 2009 global pandemics.Biochem Biophys Res Commun. 2009 Sep 18;387(2):405-8. doi: 10.1016/j.bbrc.2009.07.040. Epub 2009 Jul 15. Biochem Biophys Res Commun. 2009. PMID: 19615337 Free PMC article.
-
N-glycan structures of human alveoli provide insight into influenza A virus infection and pathogenesis.FEBS J. 2018 May;285(9):1611-1634. doi: 10.1111/febs.14431. Epub 2018 Apr 11. FEBS J. 2018. PMID: 29542865
-
Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry.Viruses. 2019 May 20;11(5):458. doi: 10.3390/v11050458. Viruses. 2019. PMID: 31137516 Free PMC article. Review.
-
[Advances in the structure and function of pandemic A/H1N1/2009 influenza virus HA protein].Bing Du Xue Bao. 2012 Jun;28(4):444-52. Bing Du Xue Bao. 2012. PMID: 22978172 Review. Chinese.
Cited by
-
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition.bioRxiv [Preprint]. 2020 May 1:2020.04.07.030445. doi: 10.1101/2020.04.07.030445. bioRxiv. 2020. Update in: Sci Rep. 2020 Sep 14;10(1):14991. doi: 10.1038/s41598-020-71748-7. PMID: 32511307 Free PMC article. Updated. Preprint.
-
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.Sci Rep. 2020 Sep 14;10(1):14991. doi: 10.1038/s41598-020-71748-7. Sci Rep. 2020. PMID: 32929138 Free PMC article.
References
-
- Colman P. Structure-Based Drug Discovery: An Overview. Royal Society of Chemistry. 2006
-
- Itzstein Mv, Wu W-Y, Kok GB, Pegg MS, Dyason JC, Jin B, Phan TV, Smythe ML, White HF, Oliver SW, Colman PM, Varghese JN, Ryan DM, Woods JM, Bethell RC, Hotham VJ, Cameron JM, Penn CR. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature. 1993;363:418–423. - PubMed
-
- Newhouse EI, Xu D, Markwick PRL, Amaro RE, Pao HC, Wu KJ, Alam M, McCammon JA, Li WW. Mechanism of Glycan Receptor Recognition and Specificity Switch for Avian, Swine, and Human Adapted Influenza Virus Hemagglutinins: A Molecular Dynamics Perspective. Journal of the American Chemical Society. 2009;131:17430–17442. - PMC - PubMed
-
- Amaro RE, Minh DD, Cheng LS, Lindstrom WM, Jr, Olson AJ, Lin JH, Li WW, McCammon JA. Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design. J Am Chem Soc. 2007;129:7764–7765. - PubMed
-
- Udommaneethanakit T, Rungrotmongkol T, Bren U, Frecer V, Stanislav M. Dynamic Behavior of Avian Influenza A Virus Neuraminidase Subtype H5N1 in Complex with Oseltamivir, Zanamivir, Peramivir, and Their Phosphonate Analogues. Journal of Chemical Information and Modeling. 2009;49:2323–2332. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical